919.17MMarket Cap83.73P/E (TTM)
0.000High0.000Low0Volume0.000Open30.980Pre Close0.00Turnover0.00%Turnover Ratio442.57P/E (Static)29.67MShares31.06052wk High3.56P/B756.21MFloat Cap15.09052wk Low--Dividend TTM24.41MShs Float46.000Historical High--Div YieldTTM0.00%Amplitude6.660Historical Low--Avg Price1Lot Size
PetIQ(Delisted) Stock Forum
In reaction to earnings/guidance:
• $The Trade Desk (TTD.US)$+17%, $Workiva (WK.US)$ +15.3%, $Arlo Technologies (ARLO.US)$ +12%, $Array Technologies (ARRY.US)$ +10.3%, $Everbridge (EVBG.US)$ +9.7%, $Catalyst Pharmaceuticals (CPRX.US)$ +9.4%, $Halozyme Therapeutics (HALO.US)$ +8.7%, $Velo3D (VLD.US)$ +7.6%, $CyberArk (CYBR.US)$ + 6.2%, $Haemonetics (HAE.US)$ +5.8%, $Jackson Financial (JXN.US)$ +5.7% (also increases dividend), $Axon Enterprise (AXON.US)$ +4.8%, ...
• $Affirm Holdings (AFRM.US)$ +36.4% (also announces multi-year extension of exclusive partnership with SHOP in the US)
• $Robinhood (HOOD.US)$ +22.9% (Emergent Fidelity discloses 7.6% stake; Sam Bankman-Fried CEO of crypto exchange FTX is majority holder in fund)
• $Endeavor Group (EDR.US)$ +20% (in reaction to earnings)
• $Coinbase (COIN.US)$ +13% (in sympathy with HOOD news)
• $Dynavax Technologies (DVAX.US)$ +11.5% (to join ...
• $BLACKSTONE SECD LENDING FD (BXSL.US)$ : Raymond James Upgrades to Outperform from Market Perform - PT $26
• $Constellation Energy (CEG.US)$ : Guggenheim Upgrades to Buy from Neutral - PT $70 (from $51)
• $Copa Holdings (CPA.US)$ : Barclays Upgrades to Overweight from Equalweight - PT $96
• $Krispy Kreme (DNUT.US)$ : HSBC Upgrades to Buy from Hold - PT $17
• $Duolingo (DUOL.US)$ : Raymond James Upgrades to Outperform from Market Perform - PT $98
• $Endeavor Group (EDR.US)$ : Barclay...
• $Intercept Pharmaceuticals (ICPT.US)$ +25.7% (to sell license to commercialize Ocaliva outside the US to Advanz Pharma for upfront payment of $405 mln)
• $Albemarle (ALB.US)$ +13.9% (earnings reports)
• $Booking Holdings (BKNG.US)$ +10% (Booking Holdings' Outlook for a 'Busy' summer season drives the stock sharply higher)
• $AxoGen (AXGN.US)$ +9% (reports top-line results from RECON study of Avance Nerge Graft)
• $Cumulus Media (CMLS.US)$ +7.2% (an...
No comment yet